Literature DB >> 30444979

Cytotoxicity and molecular docking studies on phytosterols isolated from Polygonum hydropiper L.

Muhammad Ayaz1, Abdul Sadiq2, Abdul Wadood3, Muhammad Junaid4, Farhat Ullah4, Nadir Zaman Khan5.   

Abstract

Based on our previous studies on cytotoxic potentials of Polygonum hydropiper L, two steroidal compounds beta-sitosterol and stigmasterol were isolated from the most active fraction and were subjected to cell lines cytotoxicity. Isolated compounds were tested against HeLa, MCF-7 and NIH/3T3 cell lines following MTT assay. Furthermore, the compounds were also docked against tyrosine kinase enzyme to predict the binding mode of phytosterols in the active sites of the enzyme. Beta-sitosterol exhibited considerable cytotoxicity against NIH/3T3, HeLa and MCF-7 cell with 67.05 ± 2.08, 79.63 ± 2.34 and 71.50 ± 1.57% lethality respectively at 1 mg/ml concentration. Median inhibitory concentrations calculated from dose response curve against NIH/3T3, HeLa and MCF-7 cells were 440, 170 and 200 µg/ml respectively. Stigmasterol was more effective against MCF-7 and NIH/3T3 cells by killing 87.50 and 81.45% cancerous cells respectively at 1 mg/ml concentration. Stigmasterol showed 77.25% cyctotoxicity against HeLA cells at 1 mg/ml concentration in MTT assay. The IC50 values for HeLA, MCF-7 and NIH/3T3 cells were 170, 60 and 140 µg/ml respectively. In docking studies, the docking score for beta-sitosterol and stigmasterol were -7.266 and -4.89 respectively. The binding energies for beta-sitosterol and stigmasterol were -41.21 and -41.04 respectively. Such lower binding energies indicate that the compounds fit into the active site more strongly. Binding affinities for both compounds were -7.76 and -7.68 respectively. Both phytosterols possess significant anticancer potentials and can be effective in the prevention and treatment of several malignancies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; HeLa and MCF-7 cells; Molecular docking; NIH/3T3; Polygonum hydropiper; Tyrosine kinase

Mesh:

Substances:

Year:  2018        PMID: 30444979     DOI: 10.1016/j.steroids.2018.11.005

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  11 in total

1.  Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.

Authors:  Ashfaq Ahmad; Farhat Ullah; Abdul Sadiq; Muhammad Ayaz; Haroon Rahim; Umer Rashid; Sajjad Ahmad; Muhammad Saeed Jan; Riaz Ullah; Abdelaaty A Shahat; Hafiz Majid Mahmood
Journal:  Drug Des Devel Ther       Date:  2019-12-10       Impact factor: 4.162

2.  Antioxidant, Enzyme Inhibitory, and Molecular Docking Approaches to the Antidiabetic Potentials of Bioactive Compounds from Persicaria hydropiper L.

Authors:  Muhammad Ayaz; Abdul Sadiq; Osama F Mosa; Tariq Abdalla Zafar; Alashary Adam Eisa Hamdoon; Modawy Elnour Modawy Elkhalifa; Mohammed Ahmed Elawad; Alshebli Ahmed; Farhat Ullah; Mehreen Ghufran; Atul Kabra
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

3.  HPLC-DAD phenolics analysis, α-glucosidase, α-amylase inhibitory, molecular docking and nutritional profiles of Persicaria hydropiper L.

Authors:  Mater H Mahnashi; Yahya S Alqahtani; Bandar A Alyami; Ali O Alqarni; Sultan A Alqahl; Farhat Ullah; Abdul Sadiq; Alam Zeb; Mehreen Ghufran; Alexey Kuraev; Asif Nawaz; Muhammad Ayaz
Journal:  BMC Complement Med Ther       Date:  2022-01-27

4.  Phytochemical Analysis, α-Glucosidase and Amylase Inhibitory, and Molecular Docking Studies on Persicaria hydropiper L. Leaves Essential Oils.

Authors:  Mater H Mahnashi; Yahya S Alqahtani; Bandar A Alyami; Ali O Alqarni; Muhammad Ayaz; Mehreen Ghufran; Farhat Ullah; Abdul Sadiq; Ihsan Ullah; Ikram Ul Haq; Mohammad Khalid; H C Ananda Murthy
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.629

5.  Thyme Oil and Thymol Counter Doxorubicin-Induced Hepatotoxicity via Modulation of Inflammation, Apoptosis, and Oxidative Stress.

Authors:  Osama M Ahmed; Sanaa R Galaly; Mennah-Allah M A Mostafa; Emad M Eed; Tarek M Ali; Alzhraa M Fahmy; Mohamed Y Zaky
Journal:  Oxid Med Cell Longev       Date:  2022-02-07       Impact factor: 6.543

6.  Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway.

Authors:  Feifei Li; Youyang Shi; Yang Zhang; Xiaojuan Yang; Yi Wang; Kexin Jiang; Ciyi Hua; Chunyu Wu; Chenping Sun; Yuenong Qin; Sheng Liu
Journal:  Chin Med       Date:  2022-04-04       Impact factor: 5.455

7.  Antioxidant Molecules Isolated from Edible Prostrate Knotweed: Rational Derivatization to Produce More Potent Molecules.

Authors:  Mater H Mahnashi; Bandar A Alyami; Yahya S Alqahtani; Ali O Alqarni; Muhammad Saeed Jan; Fida Hussain; Rehman Zafar; Umer Rashid; Muhammad Abbas; Muhammad Tariq; Abdul Sadiq
Journal:  Oxid Med Cell Longev       Date:  2022-02-27       Impact factor: 7.310

8.  Prospective Evaluation of an Amide-Based Zinc Scaffold as an Anti-Alzheimer Agent: In Vitro, In Vivo, and Computational Studies.

Authors:  Wajeeha Waseem; Fareeha Anwar; Uzma Saleem; Bashir Ahmad; Rehman Zafar; Asifa Anwar; Muhammad Saeed Jan; Umer Rashid; Abdul Sadiq; Tariq Ismail
Journal:  ACS Omega       Date:  2022-07-19

9.  Molecular Docking and Biophysical Studies for Antiproliferative Assessment of Synthetic Pyrazolo-Pyrimidinones Tethered with Hydrazide-Hydrazones.

Authors:  Mabrouk Horchani; Gerardo Della Sala; Alessia Caso; Federica D'Aria; Germana Esposito; Ilaria Laurenzana; Concetta Giancola; Valeria Costantino; Hichem Ben Jannet; Anis Romdhane
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

10.  Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L.

Authors:  Mater H Mahnashi; Yahya S Alqahtani; Bandar A Alyami; Ali O Alqarni; Farhat Ullah; Abdul Wadood; Abdul Sadiq; Azam Shareef; Muhammad Ayaz
Journal:  BMC Complement Med Ther       Date:  2021-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.